quarter ending March 31, 2019 is shown as a consolidated financial statement since the Subsidiary company started on December 26, 2018. 1. Revenues from sales The Company recorded revenues from sales in the

from the construction started in 2018 such as Chulalongkorn University, Institute of Molecular Biosciences, Mahidol University and Department of Provincial Administration. Cost of sales and Gross Profit

suppliers. The plant now has been completed but still in the process of mechanical testing and improving the treatment formula. For the RDF facility in the second quarter, the Company has started to adjust

received BT50 project so that the export sales in Quarter 2 2018 was higher than Quarter 1 2019’s. For the decreased in sales of European zone, this is because sales of CHR Toyota project which was started

started from this quarter. - Restaurant business decreased THB 17.59 million, down 11% compared to the same period of last year mostly from the decline in household spending and closure of 14 non-profitable

course of increasing the distribution of products to cover the relevant areas in place of sales from one of the previous distributors whose distribution agreement had been terminated last year, and started

Jakrajutatip is the true beneficial owner and the controller, which started to hold the Company’s shares since March 10, 2015). 1.2) is a major shareholder and a director of the Lessor. 2) Ms. Pimauma

Baht 4.22 million. In addition, the Company’s subsidiaries’ expenses of employees were Baht 4.13 million but its subsidiaries has not yet started its operations. (6) Share of profit (loss) from

(north), Lamphun, which started to recognize revenue in 2019. • Condominium project in Hat Yai Songkhla province recognized revenue in this quarter as the first quarter. • Condominium project in Patong

of food business by started to recognize from Bake Cheese Tart (Thailand) Company Limited in January 2019, Eastern Cruisine (Thailand) Company Limited and Crepe & Co. Development Company Limited in